國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Delta opioid receptor pharmacology a...

Jutkiewicz, Emily M.

Delta opioid receptor pharmacology and therapeutic applications

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Delta opioid receptor pharmacology and therapeutic applicationsedited by Emily M. Jutkiewicz.
其他作者:	Jutkiewicz, Emily M.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	viii, 345 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	OpioidsReceptors.
電子資源:	https://doi.org/10.1007/978-3-319-95133-1
ISBN:	9783319951331$q(electronic bk.)

Delta opioid receptor pharmacology and therapeutic applications
Delta opioid receptor pharmacology and therapeutic applications[electronic resource] /edited by Emily M. Jutkiewicz. - Cham :Springer International Publishing :2018. - viii, 345 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2470171-2004 ;. - Handbook of experimental pharmacology ;208..

Part 1. DOPR Ligands -- 1. Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept -- 2. Multifunctional Opioid Ligands -- 3. Contribution of Delta-Opioid Receptors to Pathophysiological Events Explored by Endogenous Enkephalins -- Part 2. DOPR Signaling -- 4. Ligand-Directed Signaling at the Delta Opioid Receptor -- 5. Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons -- 6. Evidence and Function Relevance of Native DOR-MOR Heteromers -- Part 3. DOPR and Disease -- 8. The Delta Opioid Receptor in Pain Control -- 9. Delta Opioid Receptors and Modulation of Mood and Emotion -- 10. Delta Opioid Pharmacology in Relation to Alcohol Behaviors -- 11. Delta Opioid Receptors: Learning and Motivation -- 12. Delta Opioid Pharmacology in Parkinson's Disease -- 13. Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders -- 14. Delta Opioid Receptors and Cardioprotection -- 15. The Roles of Opioid Receptors in Cutaneous Wound Healing.

This volume describes our current understanding of the biological role of the delta-opioid receptor (DOR) system, focusing on its unique mechanisms of receptor trafficking and signaling in disease states. Part 1 covers the endogenous ligands that regulate the DOR system as well as novel compounds and therapies used to modulate the DOR system. Part 2 describes new insights into the localization and trafficking of the DOR and how ligand-directed signaling alters the fate of the receptor. Part 3 concentrates on the potential role of the DOR system in disease states, such as pain, mood, addiction, and Parkinson's disease. Throughout the book, the DOR system as a target for drug development will be discussed.

ISBN: 9783319951331$q(electronic bk.)

Standard No.: 10.1007/978-3-319-95133-1doiSubjects--Topical Terms:

301776
Opioids
--Receptors.

LC Class. No.: RB127 / .D458 2018

Dewey Class. No.: 615.7822

Delta opioid receptor pharmacology and therapeutic applications
LDR:02888nmm a2200337 a 4500 001 544415
003 DE-He213
005 20190308092129.0
006 m d
007 cr nn 008maaau
008 190508s2018 gw s 0 eng d
020 $a 9783319951331$q(electronic bk.)
020 $a 9783319951317$q(paper)
024 7 $a 10.1007/978-3-319-95133-1 $2 doi
035 $a 978-3-319-95133-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RB127 $b .D458 2018
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.7822 $2 23
090 $a RB127 $b .D366 2018
245 0 0 $a Delta opioid receptor pharmacology and therapeutic applications $h [electronic resource] / $c edited by Emily M. Jutkiewicz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a viii, 345 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.247
505 0 $a Part 1. DOPR Ligands -- 1. Delta Opioid Receptor (DOR) Ligands and Pharmacology: Development of Indolo- and Quinolinomorphinan Derivatives Based on the Message-Address Concept -- 2. Multifunctional Opioid Ligands -- 3. Contribution of Delta-Opioid Receptors to Pathophysiological Events Explored by Endogenous Enkephalins -- Part 2. DOPR Signaling -- 4. Ligand-Directed Signaling at the Delta Opioid Receptor -- 5. Delta Opioid Receptor Expression and Function in Primary Afferent Somatosensory Neurons -- 6. Evidence and Function Relevance of Native DOR-MOR Heteromers -- Part 3. DOPR and Disease -- 8. The Delta Opioid Receptor in Pain Control -- 9. Delta Opioid Receptors and Modulation of Mood and Emotion -- 10. Delta Opioid Pharmacology in Relation to Alcohol Behaviors -- 11. Delta Opioid Receptors: Learning and Motivation -- 12. Delta Opioid Pharmacology in Parkinson's Disease -- 13. Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders -- 14. Delta Opioid Receptors and Cardioprotection -- 15. The Roles of Opioid Receptors in Cutaneous Wound Healing.
520 $a This volume describes our current understanding of the biological role of the delta-opioid receptor (DOR) system, focusing on its unique mechanisms of receptor trafficking and signaling in disease states. Part 1 covers the endogenous ligands that regulate the DOR system as well as novel compounds and therapies used to modulate the DOR system. Part 2 describes new insights into the localization and trafficking of the DOR and how ligand-directed signaling alters the fate of the receptor. Part 3 concentrates on the potential role of the DOR system in disease states, such as pain, mood, addiction, and Parkinson's disease. Throughout the book, the DOR system as a target for drug development will be discussed.
650 0 $a Opioids $x Receptors. $3 301776
650 0 $a Pharmacology, Experimental. $3 274313
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Neurosciences. $3 211508
650 2 4 $a Human Physiology. $3 274509
700 1 $a Jutkiewicz, Emily M. $3 822949
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v 208. $3 559421
856 4 0 $u https://doi.org/10.1007/978-3-319-95133-1
950 $a Biomedical and Life Sciences (Springer-11642)